Epicrispr Biotechnologies
South San Francisco, US · Founded 2018 · 51 employees on LinkedIn · 1 known investors
Epic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines. The company serves the biotech/medtech sector with advanced tools for precise gene expression control and disease treatment.
Founders & leadership
Epicrispr Biotechnologies was founded in 2018 by Lei Stanley Qi.
Board
AL
Andrew LamBoard director
AL
Anran LiBoard director
JK
Jennifer KingBoard director
EC
Eric CrombezBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$176.8M disclosed across 1 round · 2018
▶$176.8MraisedAug 2026 · 47 investors · BiotechnologyRule 506(b)
▶$176.8MraisedAug 2026 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amber SalzmanExecutive Officer, Director
- Haorui ZhangExecutive Officer, Director
- Lei QiDirector
- Andrew LamDirector
- Jennifer KingDirector
- Eric CrombezDirector
- Anran LiDirector
- Offering amount
- $212.8M
- Amount sold
- $176.8M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Epicrispr Biotechnologies do?
- Epic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines. The company serves the biotech/medtech sector with advanced tools for precise gene expression control and disease treatment.
- Who founded Epicrispr Biotechnologies?
- Epicrispr Biotechnologies was founded by Lei Stanley Qi in 2018.
- Who are Epicrispr Biotechnologies's investors?
- Epicrispr Biotechnologies's investors include Ally Bridge Group.
- How much funding has Epicrispr Biotechnologies raised?
- Epicrispr Biotechnologies has disclosed $176.8M raised across 1 round.
- Where is Epicrispr Biotechnologies headquartered?
- Epicrispr Biotechnologies is headquartered in South San Francisco, US.